![Andrew Turner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Turner
Keine laufenden Positionen mehr
Health Technology
Profil
Andrew Turner is the founder of BioRexis Pharmaceutical Corp.
which was founded in 2002.
He also worked as a Director-Technology Development at PhaseBio Pharmaceuticals, Inc. and as a Principal at Principia Pharmaceutical Corp.
Ehemalige bekannte Positionen von Andrew Turner
| Unternehmen | Position | Ende |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Gründer | - |
Principia Pharmaceutical Corp
 Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and biopharmaceuticals for serious chronic diseases | Corporate Officer/Principal | - |
| PHASEBIO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
PhaseBio Pharmaceuticals, Inc.
 PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases | Health Technology |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Develops protein therapeutics and biopharmaceuticals for serious chronic diseases | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures and provides novel protein and peptide drugs | Health Technology |
